Dr. Ethan Jacob Wajswol, MD

Dr. Wajswol practices at Piedmont Cartersville Medical Center in Cartersville, Georgia, part of Piedmont Healthcare.

Dr. Wajswol's NPI, 1366076945, was assigned on February 24, 2020. Dr. Wajswol graduated from Rutgers New Jersey Medical School in 2020. Dr. Wajswol holds Florida license ME153288.

Dr. Wajswol's primary practice is Piedmont Cartersville Medical Center, at 960 Joe Frank Harris Parkway, Cartersville, GA 30120 in Bartow County. The practice phone is (470) 490-1000.

Dr. Wajswol's primary practice is Piedmont Cartersville Medical Center in Cartersville, Georgia, part of Piedmont Healthcare. Dr. Wajswol is also affiliated with Northside Hospital Atlanta. The medical group on file is Georgia Urology. Dmand AI also links Dr. Wajswol to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wajswol practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Wajswol's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Wajswol's licenses on file in 2 states: Florida and Georgia.

CMS counts 16 Medicare patients who saw Dr. Wajswol in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wajswol's median patient age at 64, with 31% women.

In 2024, Dr. Wajswol wrote 370 Medicare Part D claims for 201 patients. 91% of them were for generic drugs. CMS names the drug for 248 of them, across 9 drugs with 11 or more claims each, at $14,473 in total drug cost. In 2023, CMS named 188 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wajswol for performance year 2024, reported as part of a group. Dr. Wajswol accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of prostate resection by Dr. Wajswol, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Wajswol, published from 2017 to 2024. 2019 was the busiest year, with 13. The most frequent topics are Prostatic Neoplasms, Prostate and Embolization, Therapeutic. Dr. Wajswol has published most often in J Vasc Interv Radiol. Dr. Wajswol's most frequent co-authors are Ashutosh Tewari, MD, Rolla T. Nuoman and Ardeshir Rustom Rastinehad, DO.

CMS Open Payments shows 79 general payments to Dr. Wajswol from 21 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 89% of the total. Coloplast Corp paid the most, $1,432.

Dr. Wajswol graduated from Rutgers New Jersey Medical School in 2020.

Dr. Wajswol is in network with 4 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.